Lijuan Xu - Search Results

Year	Number of Results
2004	1
2005	1
2006	1
2007	2
2008	1
2009	5
2010	9
2011	7
2012	12
2013	16
2014	12
2015	22
2016	20
2017	22
2018	30
2019	20
2020	23
2021	31
2022	30
2023	31
2024	8

1

Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals.

Xu L, Zhang X, Zhao Y, Gang X, Zhou T, Han J, Cao Y, Qi B, Song S, Wang X, Liang Y. Xu L, et al. Elife. 2023 Jan 4;12:e81198. doi: 10.7554/eLife.81198. Elife. 2023. PMID: 36598818 Free PMC article.

2

Engineered Cytokine-Primed Extracellular Vesicles with High PD-L1 Expression Ameliorate Type 1 Diabetes.

Wang L, Qi C, Cao H, Zhang Y, Liu X, Qiu L, Wang H, Xu L, Wu Z, Liu J, Wang S, Kong D, Wang Y. Wang L, et al. Among authors: xu l. Small. 2023 Sep;19(38):e2301019. doi: 10.1002/smll.202301019. Epub 2023 May 20. Small. 2023. PMID: 37209021

3

Profiling of small-molecule necroptosis inhibitors based on the subpockets of kinase-ligand interactions.

Xu L, Zhuang C. Xu L, et al. Med Res Rev. 2023 Nov;43(6):1974-2024. doi: 10.1002/med.21968. Epub 2023 Apr 29. Med Res Rev. 2023. PMID: 37119044 Review.

4

A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease.

Sun Y, Xu L, Zheng D, Wang J, Liu G, Mo Z, Liu C, Zhang W, Yu J, Xing C, He L, Zhuang C. Sun Y, et al. Among authors: xu l. Redox Biol. 2023 Aug;64:102793. doi: 10.1016/j.redox.2023.102793. Epub 2023 Jun 24. Redox Biol. 2023. PMID: 37385075 Free PMC article.

5

HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex.

Zhao P, Yuan F, Xu L, Jin Z, Liu Y, Su J, Yuan L, Peng L, Wang C, Zhang G. Zhao P, et al. Among authors: xu l. Cancer Lett. 2023 Aug 10;569:216305. doi: 10.1016/j.canlet.2023.216305. Epub 2023 Jul 7. Cancer Lett. 2023. PMID: 37423558

6

Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present).

Xu L, Zhang W, Zhuang C. Xu L, et al. Expert Opin Ther Pat. 2023 Feb;33(2):101-124. doi: 10.1080/13543776.2023.2195548. Epub 2023 Mar 28. Expert Opin Ther Pat. 2023. PMID: 36960668 Review.

7

Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease.

Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z. Zhao W, et al. Among authors: xu l. ACS Chem Neurosci. 2022 Jun 15;13(12):1697-1713. doi: 10.1021/acschemneuro.2c00172. Epub 2022 May 23. ACS Chem Neurosci. 2022. PMID: 35607807 Review.

8

Efficacy and Safety of Meal Replacement in Patients With Type 2 Diabetes.

Ye W, Xu L, Ye Y, Zeng F, Lu X, Li Y, Liu L. Ye W, et al. Among authors: xu l. J Clin Endocrinol Metab. 2023 Oct 18;108(11):3041-3049. doi: 10.1210/clinem/dgad273. J Clin Endocrinol Metab. 2023. PMID: 37192345

9

Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway.

Zhang X, Han Q, Hou R, Xu L, Zhang W, Xing C, Xue L, Zhuang C. Zhang X, et al. Among authors: xu l. J Med Chem. 2023 Apr 13;66(7):5261-5278. doi: 10.1021/acs.jmedchem.3c00197. Epub 2023 Mar 12. J Med Chem. 2023. PMID: 36908007

10

Incidence and risk factors of early transient intraocular pressure elevation after canaloplasty for primary open-angle glaucoma.

Xu L, Zhang X, Cao Y, Zhao Y, Gu J, Ye W, Wang X, Li J, Ren R, Liang Y. Xu L, et al. J Zhejiang Univ Sci B. 2023 Apr 15;24(4):366-370. doi: 10.1631/jzus.B2200485. J Zhejiang Univ Sci B. 2023. PMID: 37056213 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

270 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year